Business · 19/12/2011Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Evaluating Sex Differences in Medical Device Clinical Trials
Summary
The Food and Drug Administration (FDA) has published a draft guidance document that provides recommendations for evaluating sex differences in medical device clinical trials, aiming to ensure that these differences are adequately addressed in clinical trials.
Original source language: Federal Register — Health and Human ServicesOpen original release →